How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease
Abstract
Arthritis in the K/BxN mouse model results from pathogenic immunoglobulins (Igs) that recognize the ubiquitous cytoplasmic enzyme glucose-6-phosphate isomerase (GPI). But how is a joint-specific disease of autoimmune and inflammatory nature induced by systemic self-reactivity? No unusual amounts or sequence, splice or modification variants of GPI expression were found in joints. Instead, immunohistological examination revealed the accumulation of extracellular GPI on the lining of the normal articular cavity, most visibly along the cartilage surface. In arthritic mice, these GPI deposits were amplified and localized with IgG and C3 complement. Similar deposits were found in human arthritic joints. We propose that GPI-anti-GPI complexes on articular surfaces initiate an inflammatory cascade via the alternative complement pathway, which is unbridled because the cartilage surface lacks the usual cellular inhibitors. This may constitute a generic scenario of arthritogenesis, in which extra-articular proteins coat the cartilage or joint extracellular matrix.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Tissue property-dependent events, microbleeding, neural stimulation, cell senescence and oncogenic mutations in pre-neoplastic cells have been shown to trigger interactions between immune cells and non-immune tissues.
“Furthermore, tissue property-dependent events (49), microbleeding (52, 53), neural stimulation (54, 55), cell senescence (56, 57) and oncogenic mutations in pre-neoplastic cells have been shown to trigger these interactions.”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [49]
Interactions between immune cells and non-immune tissues play critical roles in chronic inflammatory diseases and autoimmune diseases.
“Consistently, evidence has indicated that interactions between immune cells and non-immune tissues play critical roles in chronic inflammatory diseases and autoimmune diseases (3, 41, 49–51).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [49]
Cited by
Sorted by citations
Gut-Residing Segmented Filamentous Bacteria Drive Autoimmune Arthritis via T Helper 17 Cells
Wu, H.-J., Ivanov, I. I., Darce, J., Hattori, K., Shima, T., Umesaki, Y., Littman, D. R., Benoist, C., & Mathis, D. (2010) · Immunity · doi:10.1016/j.immuni.2010.06.001 · Cited by 1,577 · see citing works
Self-citationIL-6 in inflammation, autoimmunity and cancer
Hirano, T. (2021) · International Immunology · doi:10.1093/intimm/dxaa078 · Cited by 1,453 · see citing works
“This view highlights the importance of local initiators in the target tissue as a trigger of auto-immunity (49, 51, 52, 57, 232).”
BackgroundImmunopathogenesis of Rheumatoid Arthritis
Firestein, G. S., & McInnes, I. B. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.006 · Cited by 1,301 · see citing works
Revival of the autoantibody model in rheumatoid arthritis
Hirano, T. (2002) · Nature Immunology · doi:10.1038/ni0402-342 · Cited by 29 · see citing works
- Authors
- Matsumoto, I., Maccioni, M., Lee, D. M., Maurice, M., Simmons, B., Brenner, M., Mathis, D., & Benoist, C.
- Affiliations
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Corresponding author
- Mathis, Diane
- Benoist, Christophe
- ORCID
- Venue
- Nature Immunology
- Published
- 2002-03-18
- Volume
- 3
- Issue
- 4
- Pages
- 360-365
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2160211752
- Cited by
- 329
- References
- 0
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 4 · 2023: 7 · 2022: 5 · 2021: 2 · 2020: 6 · 2019: 9 · 2018: 5 · 2017: 9 · 2016: 4 · 2015: 12 · 2014: 9 · 2013: 12 · 2012: 18
- FWCI
- 22.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (1R01 AR/AI46580-01)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
- Keywords
- phosphoglucose isomerase, autoimmune arthritis, articular cartilage, alternative complement pathway, C3 deposition, IgG, extracellular matrix
- MeSH terms
- Animals, Ankle Joint, Antibodies, Arthritis, Rheumatoid, Base Sequence, Cartilage, Articular, Cytoplasm, Disease Models, Animal, Female, Glucose-6-Phosphate Isomerase, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Molecular Sequence Data, Mice, Inbred NOD, DNA, Complementary, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review